These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1048 related articles for article (PubMed ID: 26742101)
1. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case. Ithuralde RE; Turjanski AG PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101 [TBL] [Abstract][Full Text] [Related]
2. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein. Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603 [TBL] [Abstract][Full Text] [Related]
3. Native Hydrophobic Binding Interactions at the Transition State for Association between the TAZ1 Domain of CBP and the Disordered TAD-STAT2 Are Not a Requirement. Lindström I; Dogan J Biochemistry; 2017 Aug; 56(32):4145-4153. PubMed ID: 28707474 [TBL] [Abstract][Full Text] [Related]
4. Complete Coupled Binding-Folding Pathway of the Intrinsically Disordered Transcription Factor Protein Brinker Revealed by Molecular Dynamics Simulations and Markov State Modeling. Collins AP; Anderson PC Biochemistry; 2018 Jul; 57(30):4404-4420. PubMed ID: 29990433 [TBL] [Abstract][Full Text] [Related]
5. Conformational propensities of intrinsically disordered proteins influence the mechanism of binding and folding. Arai M; Sugase K; Dyson HJ; Wright PE Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9614-9. PubMed ID: 26195786 [TBL] [Abstract][Full Text] [Related]
6. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations. Fadda E; Nixon MG Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880 [TBL] [Abstract][Full Text] [Related]
7. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000 [TBL] [Abstract][Full Text] [Related]
8. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313 [TBL] [Abstract][Full Text] [Related]
9. Anchoring intrinsically disordered proteins to multiple targets: lessons from N-terminus of the p53 protein. Huang Y; Liu Z Int J Mol Sci; 2011 Feb; 12(2):1410-30. PubMed ID: 21541066 [TBL] [Abstract][Full Text] [Related]
10. Structural divergence is more extensive than sequence divergence for a family of intrinsically disordered proteins. Borcherds W; Kashtanov S; Wu H; Daughdrill GW Proteins; 2013 Oct; 81(10):1686-98. PubMed ID: 23606624 [TBL] [Abstract][Full Text] [Related]
11. Role of electrostatic interactions in binding of peptides and intrinsically disordered proteins to their folded targets. 1. NMR and MD characterization of the complex between the c-Crk N-SH3 domain and the peptide Sos. Xue Y; Yuwen T; Zhu F; Skrynnikov NR Biochemistry; 2014 Oct; 53(41):6473-95. PubMed ID: 25207671 [TBL] [Abstract][Full Text] [Related]
12. Residual Structures and Transient Long-Range Interactions of p53 Transactivation Domain: Assessment of Explicit Solvent Protein Force Fields. Liu X; Chen J J Chem Theory Comput; 2019 Aug; 15(8):4708-4720. PubMed ID: 31241933 [TBL] [Abstract][Full Text] [Related]
13. Conserved Helix-Flanking Prolines Modulate Intrinsically Disordered Protein:Target Affinity by Altering the Lifetime of the Bound Complex. Crabtree MD; Borcherds W; Poosapati A; Shammas SL; Daughdrill GW; Clarke J Biochemistry; 2017 May; 56(18):2379-2384. PubMed ID: 28425697 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the disordered conformational ensembles of the p53 transactivation domain by cancer-associated mutations. Ganguly D; Chen J PLoS Comput Biol; 2015 Apr; 11(4):e1004247. PubMed ID: 25897952 [TBL] [Abstract][Full Text] [Related]
15. Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Wells M; Tidow H; Rutherford TJ; Markwick P; Jensen MR; Mylonas E; Svergun DI; Blackledge M; Fersht AR Proc Natl Acad Sci U S A; 2008 Apr; 105(15):5762-7. PubMed ID: 18391200 [TBL] [Abstract][Full Text] [Related]
16. Impact of Nonnative Interactions on the Binding Kinetics of Intrinsically Disordered p53 with MDM2: Insights from All-Atom Simulation and Markov State Model Analysis. Xu Q; Yang M; Ji J; Weng J; Wang W; Xu X J Chem Inf Model; 2024 Jul; 64(13):5219-5231. PubMed ID: 38916177 [TBL] [Abstract][Full Text] [Related]
17. Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch. Bah A; Vernon RM; Siddiqui Z; Krzeminski M; Muhandiram R; Zhao C; Sonenberg N; Kay LE; Forman-Kay JD Nature; 2015 Mar; 519(7541):106-9. PubMed ID: 25533957 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of Coupled Folding-upon-Binding of an Intrinsically Disordered Protein. Robustelli P; Piana S; Shaw DE J Am Chem Soc; 2020 Jun; 142(25):11092-11101. PubMed ID: 32323533 [TBL] [Abstract][Full Text] [Related]
19. Long range recognition and selection in IDPs: the interactions of the C-terminus of p53. Kannan S; Lane DP; Verma CS Sci Rep; 2016 Mar; 6():23750. PubMed ID: 27030593 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex. Miller Jenkins LM; Feng H; Durell SR; Tagad HD; Mazur SJ; Tropea JE; Bai Y; Appella E Biochemistry; 2015 Mar; 54(11):2001-10. PubMed ID: 25753752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]